001     126558
005     20240228140832.0
024 7 _ |a 10.1016/j.ccell.2015.10.005
|2 doi
024 7 _ |a pmid:26626085
|2 pmid
024 7 _ |a 1535-6108
|2 ISSN
024 7 _ |a 1878-3686
|2 ISSN
024 7 _ |a altmetric:4806726
|2 altmetric
037 _ _ |a DKFZ-2017-02586
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Gallo, Marco
|b 0
245 _ _ |a MLL5 Orchestrates a Cancer Self-Renewal State by Repressing the Histone Variant H3.3 and Globally Reorganizing Chromatin.
260 _ _ |a Cambridge, Mass.
|c 2015
|b Cell Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1508414329_7026
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Mutations in the histone 3 variant H3.3 have been identified in one-third of pediatric glioblastomas (GBMs), but not in adult tumors. Here we show that H3.3 is a dynamic determinant of functional properties in adult GBM. H3.3 is repressed by mixed lineage leukemia 5 (MLL5) in self-renewing GBM cells. MLL5 is a global epigenetic repressor that orchestrates reorganization of chromatin structure by punctuating chromosomes with foci of compacted chromatin, favoring tumorigenic and self-renewing properties. Conversely, H3.3 antagonizes self-renewal and promotes differentiation. We exploited these epigenetic states to rationally identify two small molecules that effectively curb cancer stem cell properties in a preclinical model. Our work uncovers a role for MLL5 and H3.3 in maintaining self-renewal hierarchies in adult GBM.
536 _ _ |a 312 - Functional and structural genomics (POF3-312)
|0 G:(DE-HGF)POF3-312
|c POF3-312
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a Antineoplastic Agents
|2 NLM Chemicals
650 _ 7 |a DNA-Binding Proteins
|2 NLM Chemicals
650 _ 7 |a Histones
|2 NLM Chemicals
650 _ 7 |a MLL5 protein, human
|2 NLM Chemicals
700 1 _ |a Coutinho, Fiona J
|b 1
700 1 _ |a Vanner, Robert J
|b 2
700 1 _ |a Gayden, Tenzin
|b 3
700 1 _ |a Mack, Stephen C
|b 4
700 1 _ |a Murison, Alex
|b 5
700 1 _ |a Remke, Marc
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Li, Ren
|b 7
700 1 _ |a Takayama, Naoya
|b 8
700 1 _ |a Desai, Kinjal
|b 9
700 1 _ |a Lee, Lilian
|b 10
700 1 _ |a Lan, Xiaoyang
|b 11
700 1 _ |a Park, Nicole I
|b 12
700 1 _ |a Barsyte-Lovejoy, Dalia
|b 13
700 1 _ |a Smil, David
|b 14
700 1 _ |a Sturm, Dominik
|0 P:(DE-He78)a46a5b2a871859c8e2d63d2f8c666807
|b 15
|u dkfz
700 1 _ |a Kushida, Michelle M
|b 16
700 1 _ |a Head, Renee
|b 17
700 1 _ |a Cusimano, Michael D
|b 18
700 1 _ |a Bernstein, Mark
|b 19
700 1 _ |a Clarke, Ian D
|b 20
700 1 _ |a Dick, John E
|b 21
700 1 _ |a Pfister, Stefan
|0 P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9
|b 22
|u dkfz
700 1 _ |a Rich, Jeremy N
|b 23
700 1 _ |a Arrowsmith, Cheryl H
|b 24
700 1 _ |a Taylor, Michael D
|b 25
700 1 _ |a Jabado, Nada
|b 26
700 1 _ |a Bazett-Jones, David P
|b 27
700 1 _ |a Lupien, Mathieu
|b 28
700 1 _ |a Dirks, Peter B
|b 29
773 _ _ |a 10.1016/j.ccell.2015.10.005
|g Vol. 28, no. 6, p. 715 - 729
|0 PERI:(DE-600)2074034-7
|n 6
|p 715 - 729
|t Cancer cell
|v 28
|y 2015
|x 1535-6108
909 C O |o oai:inrepo02.dkfz.de:126558
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 15
|6 P:(DE-He78)a46a5b2a871859c8e2d63d2f8c666807
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 22
|6 P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-312
|2 G:(DE-HGF)POF3-300
|v Functional and structural genomics
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2015
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CANCER CELL : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 20
|0 StatID:(DE-HGF)9920
|2 StatID
|b CANCER CELL : 2015
920 1 _ |0 I:(DE-He78)B062-20160331
|k B062
|l Pädiatrische Neuroonkologie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)B062-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21